INTEGRA LIFESCIENCES HOLDINGS CORP Proceeds from Issuance of Warrants
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Proceeds from Issuance of Warrants of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2023-02-22
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for the quarter ending 2021-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for the quarter ending 2021-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for fiscal 2022 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for fiscal 2020 was $44.56M.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from issuance of warrants for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-22 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $1.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $1.00K derived: sum of 3 quarters · filed 2023-02-22 | $44.56M 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.00K derived: sum of 2 quarters · filed 2021-11-02 | $44.56M 10-Q · filed 2021-11-02 | $44.56M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $44.56M 10-Q · filed 2021-07-29 | $44.56M derived: sum of 3 quarters · filed 2022-02-24 | $44.56M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $44.56M 10-Q · filed 2021-04-29 | $44.56M derived: sum of 2 quarters · filed 2022-02-24 | $44.56M derived: sum of 3 quarters · filed 2022-02-24 | $44.56M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2013-12-31 | $0.00 8-K · filed 2014-06-20 | |||
| 2012-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $0.00 8-K · filed 2014-06-20 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-10-24 | |||
| 2011-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $0.00 derived: sum of 2 quarters · filed 2014-06-20 | $28.45M 8-K · filed 2014-06-20 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $28.45M 10-Q · filed 2012-10-24 | ||
| 2011-06-30 | $28.45M 10-Q · filed 2012-07-31 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |